Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istodax and CHOP in Peripheral T-Cell Lymphoma
NCT01280526Phase 2Completed
- Sponsor
- LYSARC
- Start
- Jan 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in peripheral T-cell lymphoma (PTCL), sponsored by LYSARC. Started Jan 2011; status: completed.
02
Drugs
romidepsin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01280526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280526.